Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Clever Leaves becomes distributor in Germany

"We are officially licensed in Europe's largest medical cannabis market"

Clever Leaves Germany GmbH has received all of the required regulatory licenses, permits, and certifications by the German authorities to be able to distribute medical cannabis to wholesalers and around 20,000 pharmacies located in Germany. The company’s licenses, permits, and certifications in Germany include:

- Wholesale distribution license granted according to §52a under the German Medicinal Products Act (Arzneimittelgesetz)
- Certificate of Good Distribution Practice (“GDP”)
- Permit for the trade in narcotic drugs as per §3 of the German Narcotic Drugs Act (Betäubungsmittelgesetz, “BtMG”)
“Germany is one of the most important international markets for Clever Leaves. We have been developing our regulatory foundation and are confident that the suite of licenses, permits, and certifications obtained will support our platform to continue penetrating such an important market,” said Andres Fajardo, Clever Leaves' CEO. “Our local team’s expertise and experience in the pharmaceutical and medical cannabis industries will enable Clever Leaves Germany to act as a reliable partner that meets the high-quality standards and regulations of the German market and our clients,” he stated.

“As a fully licensed distributor, we are well-prepared for future changes in the distribution of medical cannabis in Germany, and we are strategically positioned to exploit the full potential of the market,” said Caroline Kliess, Managing Director at Clever Leaves Germany GmbH. “We will distribute medical cannabis products manufactured in compliance with local guidelines from our production facilities in Portugal and Colombia.”

With a population of over 83 million people, who are covered by statutory health insurance, Germany has the potential to become one of the largest state-regulated markets for medical cannabis in the world. According to the Federal Association of Statutory Health Insurance Funds, public reimbursements for medical cannabis reached a value of 123 million Euros in 2019, a 67% increase from 2018, when the number of prescriptions processed by pharmacies exceeded 267,000. In 2020, this number increased to over 340,000 in 2020, accumulating to 165 million total Euros. For 2021, the projected expansion of medical cannabis in Germany could reach over 170 million Euros.

For more information:
Clever Leaves     

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.